data_2mc7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mc7 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttt . . . . . 0 CA--C 1.561 1.372 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -112.46 -24.63 9.62 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.925 -1.11 . . . . 0.0 113.757 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -57.46 100.13 0.05 OUTLIER 'General case' 0 C--N 1.372 1.546 0 O-C-N 118.837 -2.414 . . . . 0.0 112.157 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -53.68 53.56 Favored Pre-proline 0 C--O 1.196 -1.722 1 N-CA-C 124.065 4.839 . . . . 0.0 124.065 -166.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.99 -10.01 21.04 Favored 'Trans proline' 0 C--N 1.33 -0.441 0 O-C-N 126.058 2.61 . . . . 0.0 117.651 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -102.04 0.71 35.47 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 127.357 2.263 . . . . 0.0 116.725 -166.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 120.095 3.368 . . . . 0.0 120.095 -168.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.1 mt -80.49 -38.98 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 O-C-N 119.864 -1.773 . . . . 0.0 107.814 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.321 15.7 pt -64.89 -44.99 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 120.038 -1.664 . . . . 0.0 112.36 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.17 79.97 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 117.464 -3.273 . . . . 0.0 118.054 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.93 -41.57 98.11 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 118.562 -2.587 . . . . 0.0 113.187 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mt -56.23 -46.54 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-N 111.046 -2.797 . . . . 0.0 114.881 163.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.55 -38.54 90.44 Favored 'General case' 0 CA--C 1.595 2.711 0 CA-C-O 124.511 2.101 . . . . 0.0 111.715 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.1 tp -67.42 -51.32 53.06 Favored 'General case' 0 CA--C 1.446 -3.02 0 CA-C-O 116.752 -1.595 . . . . 0.0 111.572 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 16.7 mt -58.81 -48.01 82.77 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 130.836 3.654 . . . . 0.0 112.816 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . 0.329 4.6 mt -65.78 -36.8 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.6 m -64.43 -42.36 96.05 Favored 'General case' 0 C--O 1.181 -2.523 0 O-C-N 121.805 -0.559 . . . . 0.0 111.307 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -59.46 -51.55 69.4 Favored 'General case' 0 CA--C 1.594 2.649 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 tp -44.47 -53.6 6.8 Favored 'General case' 0 C--O 1.179 -2.646 1 C-N-CA 132.47 4.308 . . . . 0.0 114.807 163.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -50.88 -50.39 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 O-C-N 119.82 -1.8 . . . . 0.0 115.795 161.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.2 tp -56.31 -47.15 79.29 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 116.357 -1.783 . . . . 0.0 111.749 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.7 m -61.99 -43.09 99.57 Favored 'General case' 0 C--N 1.426 3.931 0 CA-C-O 125.652 2.644 . . . . 0.0 109.177 -174.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.55 -42.21 78.7 Favored 'General case' 0 C--O 1.271 2.194 0 O-C-N 117.878 -3.014 . . . . 0.0 113.4 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.1 70.57 Favored 'General case' 0 C--O 1.172 -3.0 0 C-N-CA 124.753 1.221 . . . . 0.0 111.983 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.5 mt -68.75 -47.16 66.97 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-O 122.317 1.056 . . . . 0.0 111.479 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . 0.301 19.6 t90 -73.43 -46.61 47.52 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 116.878 -3.639 . . . . 0.0 113.374 -169.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -142.63 169.86 16.78 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-O 122.326 1.06 . . . . 0.0 112.64 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.43 7.7 mt 65.56 103.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.465 -2.311 0 C-N-CA 127.704 2.402 . . . . 0.0 116.603 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.3 t -92.46 129.89 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 126.1 1.76 . . . . 0.0 110.553 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 N--CA 1.414 -2.231 0 CA-C-O 115.495 -2.193 . . . . 0.0 110.759 -176.183 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttt . . . . . 0 CA--C 1.561 1.372 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -112.46 -24.63 9.62 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.925 -1.11 . . . . 0.0 113.757 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -57.46 100.13 0.05 OUTLIER 'General case' 0 C--N 1.372 1.546 0 O-C-N 118.837 -2.414 . . . . 0.0 112.157 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -53.68 53.56 Favored Pre-proline 0 C--O 1.196 -1.722 1 N-CA-C 124.065 4.839 . . . . 0.0 124.065 -166.511 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.99 -10.01 21.04 Favored 'Trans proline' 0 C--N 1.33 -0.441 0 O-C-N 126.058 2.61 . . . . 0.0 117.651 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -102.04 0.71 35.47 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 127.357 2.263 . . . . 0.0 116.725 -166.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 120.095 3.368 . . . . 0.0 120.095 -168.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.1 mt -80.49 -38.98 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 O-C-N 119.864 -1.773 . . . . 0.0 107.814 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.321 15.7 pt -64.89 -44.99 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 120.038 -1.664 . . . . 0.0 112.36 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.17 79.97 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 117.464 -3.273 . . . . 0.0 118.054 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.93 -41.57 98.11 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 118.562 -2.587 . . . . 0.0 113.187 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mt -56.23 -46.54 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-N 111.046 -2.797 . . . . 0.0 114.881 163.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.55 -38.54 90.44 Favored 'General case' 0 CA--C 1.595 2.711 0 CA-C-O 124.511 2.101 . . . . 0.0 111.715 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.1 tp -67.42 -51.32 53.06 Favored 'General case' 0 CA--C 1.446 -3.02 0 CA-C-O 116.752 -1.595 . . . . 0.0 111.572 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 16.7 mt -58.81 -48.01 82.77 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 130.836 3.654 . . . . 0.0 112.816 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . 0.329 4.6 mt -65.78 -36.8 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.6 m -64.43 -42.36 96.05 Favored 'General case' 0 C--O 1.181 -2.523 0 O-C-N 121.805 -0.559 . . . . 0.0 111.307 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -59.46 -51.55 69.4 Favored 'General case' 0 CA--C 1.594 2.649 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 tp -44.47 -53.6 6.8 Favored 'General case' 0 C--O 1.179 -2.646 1 C-N-CA 132.47 4.308 . . . . 0.0 114.807 163.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -50.88 -50.39 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 O-C-N 119.82 -1.8 . . . . 0.0 115.795 161.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.2 tp -56.31 -47.15 79.29 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 116.357 -1.783 . . . . 0.0 111.749 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.7 m -61.99 -43.09 99.57 Favored 'General case' 0 C--N 1.426 3.931 0 CA-C-O 125.652 2.644 . . . . 0.0 109.177 -174.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.55 -42.21 78.7 Favored 'General case' 0 C--O 1.271 2.194 0 O-C-N 117.878 -3.014 . . . . 0.0 113.4 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.1 70.57 Favored 'General case' 0 C--O 1.172 -3.0 0 C-N-CA 124.753 1.221 . . . . 0.0 111.983 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.5 mt -68.75 -47.16 66.97 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-O 122.317 1.056 . . . . 0.0 111.479 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . 0.301 19.6 t90 -73.43 -46.61 47.52 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 116.878 -3.639 . . . . 0.0 113.374 -169.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -142.63 169.86 16.78 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-O 122.326 1.06 . . . . 0.0 112.64 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.43 7.7 mt 65.56 103.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.465 -2.311 0 C-N-CA 127.704 2.402 . . . . 0.0 116.603 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.3 t -92.46 129.89 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 126.1 1.76 . . . . 0.0 110.553 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 N--CA 1.414 -2.231 0 CA-C-O 115.495 -2.193 . . . . 0.0 110.759 -176.183 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 ttt . . . . . 0 CA--C 1.561 1.372 0 N-CA-C 111.369 0.137 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -112.46 -24.63 9.62 Favored 'General case' 0 CA--C 1.547 0.846 0 O-C-N 120.925 -1.11 . . . . 0.0 113.757 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 23.4 tpt180 -57.46 100.13 0.05 OUTLIER 'General case' 0 C--N 1.372 1.546 0 O-C-N 118.837 -2.414 . . . . 0.0 112.157 173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -53.68 53.56 Favored Pre-proline 0 C--O 1.196 -1.722 1 N-CA-C 124.065 4.839 . . . . 0.0 124.065 -166.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.99 -10.01 21.04 Favored 'Trans proline' 0 C--N 1.33 -0.441 0 O-C-N 126.058 2.61 . . . . 0.0 117.651 -173.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.2 m-20 -102.04 0.71 35.47 Favored 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 127.357 2.263 . . . . 0.0 116.725 -166.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -64.75 -37.22 86.88 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 120.095 3.368 . . . . 0.0 120.095 -168.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 92.1 mt -80.49 -38.98 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.403 0 O-C-N 119.864 -1.773 . . . . 0.0 107.814 -176.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . 0.321 15.7 pt -64.89 -44.99 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 O-C-N 120.038 -1.664 . . . . 0.0 112.36 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.17 79.97 Favored 'General case' 0 N--CA 1.426 -1.666 0 O-C-N 117.464 -3.273 . . . . 0.0 118.054 168.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 10.0 tp -61.93 -41.57 98.11 Favored 'General case' 0 N--CA 1.436 -1.151 0 O-C-N 118.562 -2.587 . . . . 0.0 113.187 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.8 mt -56.23 -46.54 81.41 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-N 111.046 -2.797 . . . . 0.0 114.881 163.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -62.55 -38.54 90.44 Favored 'General case' 0 CA--C 1.595 2.711 0 CA-C-O 124.511 2.101 . . . . 0.0 111.715 -177.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.1 tp -67.42 -51.32 53.06 Favored 'General case' 0 CA--C 1.446 -3.02 0 CA-C-O 116.752 -1.595 . . . . 0.0 111.572 177.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . 0.284 16.7 mt -58.81 -48.01 82.77 Favored 'General case' 0 C--N 1.374 1.655 0 C-N-CA 130.836 3.654 . . . . 0.0 112.816 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . 0.329 4.6 mt -65.78 -36.8 78.43 Favored 'Isoleucine or valine' 0 CA--C 1.582 2.183 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 170.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.6 m -64.43 -42.36 96.05 Favored 'General case' 0 C--O 1.181 -2.523 0 O-C-N 121.805 -0.559 . . . . 0.0 111.307 171.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 tp -59.46 -51.55 69.4 Favored 'General case' 0 CA--C 1.594 2.649 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 174.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 17.1 tp -44.47 -53.6 6.8 Favored 'General case' 0 C--O 1.179 -2.646 1 C-N-CA 132.47 4.308 . . . . 0.0 114.807 163.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.8 t -50.88 -50.39 23.82 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.71 0 O-C-N 119.82 -1.8 . . . . 0.0 115.795 161.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 47.2 tp -56.31 -47.15 79.29 Favored 'General case' 0 C--O 1.21 -1.001 0 CA-C-O 116.357 -1.783 . . . . 0.0 111.749 175.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.7 m -61.99 -43.09 99.57 Favored 'General case' 0 C--N 1.426 3.931 0 CA-C-O 125.652 2.644 . . . . 0.0 109.177 -174.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.55 -42.21 78.7 Favored 'General case' 0 C--O 1.271 2.194 0 O-C-N 117.878 -3.014 . . . . 0.0 113.4 -174.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.65 -32.1 70.57 Favored 'General case' 0 C--O 1.172 -3.0 0 C-N-CA 124.753 1.221 . . . . 0.0 111.983 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.5 mt -68.75 -47.16 66.97 Favored 'General case' 0 C--N 1.375 1.693 0 CA-C-O 122.317 1.056 . . . . 0.0 111.479 169.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . 0.301 19.6 t90 -73.43 -46.61 47.52 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 116.878 -3.639 . . . . 0.0 113.374 -169.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -142.63 169.86 16.78 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-O 122.326 1.06 . . . . 0.0 112.64 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . 0.43 7.7 mt 65.56 103.77 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.465 -2.311 0 C-N-CA 127.704 2.402 . . . . 0.0 116.603 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.3 t -92.46 129.89 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 C-N-CA 126.1 1.76 . . . . 0.0 110.553 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 N--CA 1.414 -2.231 0 CA-C-O 115.495 -2.193 . . . . 0.0 110.759 -176.183 . . . . . . . . 0 0 . 1 stop_ save_